Current Opinion in Endocrinology Diabetes and Obesity

Papers
(The H4-Index of Current Opinion in Endocrinology Diabetes and Obesity is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Gut peptides and the microbiome: focus on ghrelin53
Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes34
Continuous glucose monitoring in the hospital: an update in the era of COVID-1925
Expert position statements: comparison of recommendations for the care of adults and youth with elevated lipoprotein(a)24
Genetics of pheochromocytoma and paraganglioma24
HDL functionality in type 1 and type 2 diabetes: new insights24
Pharmacotherapy in pediatric obesity: current evidence and landscape23
Telehealth in type 1 diabetes23
Type 2 diabetes mellitus and cognitive function: understanding the connections21
Thermal ablation in adrenal disorders: a discussion of the technology, the clinical evidence and the future20
Adult obesity and its complications: a pediatric disease?20
Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity20
Long-acting amylin analogues for the management of obesity20
Growth, body composition, and endocrine issues in Williams syndrome18
Renal function in patients following a low carbohydrate diet for type 2 diabetes: a review of the literature and analysis of routine clinical data from a primary care service over 7 years18
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia16
Gut-derived serotonin and its emerging roles in immune function, inflammation, metabolism and the gut–brain axis16
0.026124000549316